Xiaocong Pang

5PUBLICATIONS
29CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Structure-Based Drug Design to Identify Potent, Selective, and Orally Available Cyclin-Dependent Kinase 9 Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.

|Apr 10, 2026
Evolution of Drug Development Trends in Multiple Sclerosis: Analysis of Mainland China and Global Landscapes From 2004 to 2024.

Chaoyang Chen, Zhenyu Niu, Ting Yang

|Nov 17, 2025
Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization.

Lin Chen, Yanlun Gu, Yuke Chen

|Feb 07, 2023
Macrophages promote anti-androgen resistance in prostate cancer bone disease.

Xue-Feng Li, Cigdem Selli, Han-Lin Zhou

|Nov 01, 2021
SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways.

Xiaocong Pang, Junling Zhang, Xu He

Pageof 1

Frequent Collaborators

2 joint publications

Ying Zhou

1 joint publications

Xue-Feng Li

1 joint publications

Cigdem Selli

1 joint publications

Han-Lin Zhou